{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T01:52:34Z","timestamp":1782525154870,"version":"3.54.5"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,2]],"date-time":"2027-06-02T00:00:00Z","timestamp":1811894400000},"content-version":"am","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.contraception.2025.111207","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T17:11:56Z","timestamp":1757092316000},"page":"111207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Safety and effectiveness of contraception among women with chronic kidney disease: A systematic review"],"prefix":"10.1016","volume":"159","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7972-9117","authenticated-orcid":false,"given":"Katherine","family":"Kortsmit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Burgner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Folger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2213-6382","authenticated-orcid":false,"given":"Naomi K.","family":"Tepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura K.","family":"Whiteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2025.111207_bib1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.kint.2020.02.010","article-title":"Nomenclature for kidney function and disease: report of a kidney disease: improving global outcomes (KDIGO) consensus conference","volume":"97","author":"Levey","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.contraception.2025.111207_bib2","unstructured":"Centers for Disease Control and Prevention. Chronic kidney disease basics. \u3008https:\/\/www.cdc.gov\/kidney-disease\/about\/?CDC_AAref_Val=https:\/\/www.cdc.gov\/kidneydisease\/basics.html\u3009 (accessed September 2, 2025)."},{"key":"10.1016\/j.contraception.2025.111207_bib3","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases. What is chronic kidney disease in adults? \u3008https:\/\/www.niddk.nih.gov\/health-information\/kidney-disease\/chronic-kidney-disease-ckd\/what-is-chronic-kidney-disease\u3009 (accessed September 2, 2025)."},{"key":"10.1016\/j.contraception.2025.111207_bib4","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases. Managing chronic kidney disease. \u3008https:\/\/www.niddk.nih.gov\/health-information\/kidney-disease\/chronic-kidney-disease-ckd\/managing\u3009 (accessed September 2, 2025)."},{"key":"10.1016\/j.contraception.2025.111207_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3390\/jcm7110415","article-title":"Pregnancy in chronic kidney disease: need for higher awareness. A pragmatic review focused on what could be improved in the different CKD stages and phases","volume":"7","author":"Piccoli","year":"2018","journal-title":"J Clin Med"},{"key":"10.1016\/j.contraception.2025.111207_bib6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/j.ackd.2020.04.003","article-title":"Chronic kidney disease and pregnancy","volume":"27","author":"Reynolds","year":"2020","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.contraception.2025.111207_bib7","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2022.06.008","article-title":"KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease","volume":"102","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.contraception.2025.111207_bib8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/5584_2016_84","article-title":"Hypertension in chronic kidney disease","volume":"956","author":"Hamrahian","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.contraception.2025.111207_bib9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11239-016-1437-1","article-title":"Venous thromboembolism in chronic kidney disease: epidemiology, the role of proteinuria, CKD severity and therapeutics","volume":"43","author":"Dobrowolski","year":"2017","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.contraception.2025.111207_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038401","article-title":"Associations between multimorbidity and adverse clinical outcomes in patients with chronic kidney diesease: a systematic review and meta-analysis","volume":"10","author":"Sullivan","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.contraception.2025.111207_bib11","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41581-022-00616-6","article-title":"Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease","volume":"18","author":"Matsushita","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.contraception.2025.111207_bib12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.semarthrit.2019.10.006","article-title":"A review of non-immune mediated kidney disease in systemic lupus erythematosus: a hypotetical model of putative risk factors","volume":"50","author":"Falasinnu","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.contraception.2025.111207_bib13","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.0000000804","article-title":"Management of kidney disease with sickle cell disease","author":"Abbasi","year":"2025","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.contraception.2025.111207_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1681\/ASN.2007030308","article-title":"Chronic kidney disease increases risk for venous thromboembolism","volume":"19","author":"Wattanakit","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.contraception.2025.111207_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/916760","article-title":"Primary nephrotic syndrome in adults as a risk factor for pulmonary embolism: an up-to-date review of the literature","author":"Mirrakhimov","year":"2014","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.contraception.2025.111207_bib16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.thromres.2005.03.030","article-title":"Thromboembolic complications in the nephrotic syndrome: pathopysiology and clinical management","volume":"118","author":"Singhal","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.contraception.2025.111207_bib17","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/ndt\/gfx212","article-title":"Risk and complications of venous thromboembolism in dialysis patients","volume":"33","author":"Molnar","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.contraception.2025.111207_bib18","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/ki.2013.547","article-title":"The three-year incidence of fracture in chronic kidney disease","volume":"86","author":"Naylor","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.contraception.2025.111207_bib19","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.kint.2017.07.021","article-title":"Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation","volume":"92","author":"Pimentel","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.contraception.2025.111207_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2147\/IJNRD.S326464","article-title":"Hyperkalemia in chronic kidney disease: links, risks and management","volume":"15","author":"Sarnowski","year":"2022","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1016\/j.contraception.2025.111207_bib21","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2215\/CJN.09770819","article-title":"Contraception and CKD","volume":"15","author":"Burgner","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.contraception.2025.111207_bib22","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.contraception.2025.111207_bib23","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s40620-020-00717-0","article-title":"Contraception in chronic kidney disease: a best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology","volume":"33","author":"Attini","year":"2020","journal-title":"J Nephrol"},{"key":"10.1016\/j.contraception.2025.111207_bib24","doi-asserted-by":"crossref","first-page":"F535","DOI":"10.1152\/ajprenal.00602.2014","article-title":"Transdermal contraception and the renin-angiotensin-aldoesterone system in premenopausal women","volume":"308","author":"Odutayo","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.contraception.2025.111207_bib25","doi-asserted-by":"crossref","first-page":"R807","DOI":"10.1152\/ajpregu.2001.280.3.R807","article-title":"Effect of oral contraceptives on the renin angiotensin system and renal function","volume":"280","author":"Kang","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.contraception.2025.111207_bib26","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/01.ASN.0000114555.16297.5A","article-title":"Effects of oral contraceptive use on the renal and systemic vascular response to angiotensin II infusion","volume":"15","author":"Ahmed","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.contraception.2025.111207_bib27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1053\/j.ackd.2004.07.001","article-title":"Pharmacokinetics of estrogen and progesterone in chronic kidney disease","volume":"11","author":"Anderson","year":"2004","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.contraception.2025.111207_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7304a1","article-title":"U.S. Medical Eligibility Criteria for contraceptive use, 2024","volume":"73","author":"Nguyen","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.contraception.2025.111207_bib29","unstructured":"Kortsmit K., Curtis K., Nguyen A., Whiteman M., Folger S. Safety and effectiveness of contraception among women with chronic kidney disease: a systematic review. International prospective register of systeamtic reviews. 2022. (\u3008https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42022350951\u3009)."},{"key":"10.1016\/j.contraception.2025.111207_bib30","unstructured":"Veritas Health Innovation. Covidence systematic review software. \u3008https:\/\/www.covidence.org\u3009 (accessed September 2, 2025)."},{"key":"10.1016\/j.contraception.2025.111207_bib31","article-title":"Chapter 8: assessing risk of bias in a randomized trial","author":"Higgins","year":"2022","journal-title":"Cochrane Handbook for Systematic Reviews of Interventions version 63"},{"key":"10.1016\/j.contraception.2025.111207_bib32","article-title":"Chapter 25: assessing risk of bias in a non-randomized study","author":"Sterne","year":"2022","journal-title":"Cochrane Handbook for Systematic Reviews of Interventions version 63"},{"key":"10.1016\/j.contraception.2025.111207_bib33","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.contraception.2016.07.011","article-title":"Drug interactions between hormonal contraceptives and psychotropic drugs: a systematic review","volume":"94","author":"Berry-Bibee","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111207_bib34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.contraception.2025.111207_bib35","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2025.111207_bib36","unstructured":"GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. 2022. \u3008https:\/\/www.gradepro.org\/\u3009."},{"key":"10.1016\/j.contraception.2025.111207_bib37","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3747\/pdi.2016.00154","article-title":"Eosinophilia in peritoneal effluent due to a levonorgestrel-releasing intrauterine system in a woman on peritoneal dialysis","volume":"37","author":"Chen","year":"2017","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.contraception.2025.111207_bib38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1028-4559(08)60017-0","article-title":"Concomitant serratia marcescens peritonitis and tubo-ovarian abscess associated with peritoneal dialysis and intrauterine device placement","volume":"46","author":"Chen","year":"2007","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111207_bib39","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1177\/089686080202200420","article-title":"Intrauterine device-related peritonitis in a patient on CAPD","volume":"22","author":"Plaza","year":"2002","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.contraception.2025.111207_bib40","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1056\/NEJM199908123410718","article-title":"Levonorgestrel-releasing intrauterine device for the treatment of menometrorrhagia in a woman on hemodialysis","volume":"341","author":"Fedele","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2025.111207_bib41","first-page":"24","article-title":"Pneumococcal peritonitis complicating CAPD - was the indwelling intrauterine device to blame?","volume":"35","author":"Korzets","year":"1991","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.contraception.2025.111207_bib42","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/S0002-9378(11)90772-8","article-title":"Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis","volume":"168","author":"Price","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111207_bib43","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2215\/CJN.01581105","article-title":"Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years","volume":"1","author":"Dicks","year":"2006","journal-title":"Clin J Am Soc Neph"},{"issue":"8","key":"10.1016\/j.contraception.2025.111207_bib44","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1177\/0091270006289973","article-title":"Effect of drospirenone on serum potassium and drospirenone pharmacokinetics in women with normal or impaired renal function","volume":"46","author":"Sch\u00fcrmann","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2025.111207_bib45","unstructured":"Centers for Disease Control and Prevention. Supplementary Appendix. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. \u3008https:\/\/stacks.cdc.gov\/view\/cdc\/156516\u3009, 2024 (accessed September 2, 2025)."},{"key":"10.1016\/j.contraception.2025.111207_bib46","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1093\/ndt\/gfq179","article-title":"Chronic kidney disease and venous thromboembolism: a prospective study","volume":"25","author":"Folsom","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.contraception.2025.111207_bib47","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCULATIONAHA.107.716951","article-title":"High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study","volume":"117","author":"Mahmoodi","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.contraception.2025.111207_bib48","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.amjmed.2007.08.042","article-title":"Venous thromboembolism in patients hospitalized with nephrotic syndrome","volume":"121","author":"Kayali","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.contraception.2025.111207_bib49","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3389\/fneur.2019.00993","article-title":"Oral contraceptive use and increased risk of stroke: a dose-response meta-analysis of observational studies","volume":"10","author":"Li","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.contraception.2025.111207_bib50","first-page":"CD011054","article-title":"Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke","volume":"2015","author":"Roach","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2025.111207_bib51","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin-only contraception and thromboembolism: a systematic review","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111207_bib52","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.contraception.2016.10.005","article-title":"Nonoral combined hormonal contraceptives and thromboembolism: a systematic review","volume":"95","author":"Tepper","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111207_bib53","article-title":"Combined oral contraceptives: venous thrombosis","volume":"2014","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2025.111207_bib54","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/2047487318774847","article-title":"Association between progestin-only contraceptive use and cardiometabolic outcomes: a systematic review and meta-analysis","volume":"25","author":"Glisic","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.contraception.2025.111207_bib55","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/AOG.0000000000004896","article-title":"Association of progestogens and venous thromboembolism among women of reproductive age","volume":"140","author":"Cockrum","year":"2022","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2025.111207_bib56","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.ajkd.2020.02.450","article-title":"Risks of hip and nonvertebral fractures in patients with CKD G3a-G5D: a systematic review and meta-analysis","volume":"76","author":"Vilaca","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.contraception.2025.111207_bib57","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.contraception.2005.12.010","article-title":"Progestogen-only contraception and bone mineral density: a systematic review","volume":"73","author":"Curtis","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2025.111207_bib58","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1749-6632.1995.tb31386.x","article-title":"Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity","volume":"761","author":"Muhn","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.contraception.2025.111207_bib59","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/j.ajkd.2021.03.008","article-title":"A unifying approach for GFR estimation: recommendations of the NKF-ASN task force on reassessing the inclusion of race in diagnosing kidney disease","volume":"78","author":"Delgado","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.contraception.2025.111207_bib60","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/j.ajkd.2021.03.008","article-title":"Reassessing the inclusion of race in diagnosing kidney diseases: an interim report from the NKF-ASN task force","volume":"78","author":"Delgado","year":"2021","journal-title":"Am J Kidney Dis"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425003981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782425003981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T02:16:31Z","timestamp":1780712191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782425003981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":60,"alternative-id":["S0010782425003981"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2025.111207","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and effectiveness of contraception among women with chronic kidney disease: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2025.111207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111207"}}